(Q42446048)

31 October 2017

title

Kinetics of nigral degeneration in a chronic model of MPTP-treated mice (English)

1 reference

31 October 2017

1

1 reference

31 October 2017

Dovero S

2

1 reference

31 October 2017

Bioulac B

series ordinal

3

1 reference

31 October 2017

Gross CE

series ordinal

4

1 reference

31 October 2017

language of work or name

English

0 references

publication date

1 September 1997

1 reference

31 October 2017

1 reference

31 October 2017

volume

234

1 reference

31 October 2017

issue

1

1 reference

31 October 2017

page(s)

47-50

1 reference

MPTP induced hemiparkinsonism in monkeys: behavioral, mechanographic, electromyographic and immunohistochemical studies.

31 October 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3940%2897%2900663-0

7 January 2021

Compensatory effects of glutamatergic inputs to the substantia nigra pars compacta in experimental parkinsonism.

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3940%2897%2900663-0

7 January 2021

Presymptomatic revelation of experimental parkinsonism.

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3940%2897%2900663-0

7 January 2021

https://api.crossref.org/works/10.1016%2FS0304-3940%2897%2900663-0

1 reference

7 January 2021

A chronic MPTP model reproducing the slow evolution of Parkinson's disease: evolution of motor symptoms in the monkey.

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3940%2897%2900663-0

7 January 2021

Pattern of brain destruction in Parkinson's and Alzheimer's diseases.

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3940%2897%2900663-0

7 January 2021

A primate model of parkinsonism: selective destruction of dopaminergic neurons in the pars compacta of the substantia nigra by N-methyl-4-phenyl-1,2,3,6-tetrahydropyridine

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3940%2897%2900663-0

7 January 2021

The nigrostriatal dopaminergic system in MPTP-treated mice shows more prominent recovery by syngeneic adrenal medullary graft than by allogeneic or xenogeneic graft

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3940%2897%2900663-0

7 January 2021

Distribution of noradrenaline and dopamine (3-hydroxytyramine) in the human brain and their behavior in diseases of the extrapyramidal system

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3940%2897%2900663-0

7 January 2021

Animal models of Parkinson's disease: an empirical comparison with the phenomenology of the disease in man.

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3940%2897%2900663-0

7 January 2021

MPTP mechanisms of neurotoxicity and their implications for Parkinson's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3940%2897%2900663-0

7 January 2021

The neurotoxin MPTP causes degeneration of specific nucleus A8, A9 and A10 dopaminergic neurons in the mouse

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3940%2897%2900663-0

7 January 2021

The MPTP-treated mouse as a model of parkinsonism: how good is it?

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3940%2897%2900663-0

7 January 2021

Some features of the nigrostriatal dopaminergic neurotoxin 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) in the mouse

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3940%2897%2900663-0

7 January 2021

Time course and morphology of dopaminergic neuronal death caused by the neurotoxin 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3940%2897%2900663-0

7 January 2021

Selective nigral toxicity after systemic administration of 1-methyl-4-phenyl-1,2,5,6-tetrahydropyrine (MPTP) in the squirrel monkey

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3940%2897%2900663-0

7 January 2021

Midbrain dopaminergic neurons in the mouse: computer-assisted mapping

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3940%2897%2900663-0

7 January 2021

Strain differences in systemic 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine neurotoxicity in mice correlate best with monoamine oxidase activity at the blood-brain barrier

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3940%2897%2900663-0

7 January 2021

Striatal dopamine deficiency in Parkinson's disease: role of aging

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3940%2897%2900663-0

7 January 2021

Deficits in behavioral initiation and execution processes in monkeys with 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced parkinsonism.

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3940%2897%2900663-0

7 January 2021

A mathematical model of pathogenesis in idiopathic parkinsonism

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3940%2897%2900663-0

7 January 2021

Relative sparing in Parkinson's disease of substantia nigra dopamine neurons containing calbindin-D28K.

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3940%2897%2900663-0

7 January 2021

10.1016/S0304-3940(97)00663-0

Identifiers

DOI

1 reference

31 October 2017

1 reference